Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Induction of immunologic memory following primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in infants.

Knuf M, Pankow-Culot H, Grunert D, Rapp M, Panzer F, Köllges R, Fanic A, Habib A, Borys D, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2012 Jan;31(1):e31-6. doi: 10.1097/INF.0b013e3182323ac2.

PMID:
21909049
2.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
3.

Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.

Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Review.

PMID:
19325447
4.

Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV).

Croxtall JD, Keating GM.

Paediatr Drugs. 2009;11(5):349-57. doi: 10.2165/11202760-000000000-00000. Review.

PMID:
19725600
5.

10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

Prymula R, Schuerman L.

Expert Rev Vaccines. 2009 Nov;8(11):1479-500. doi: 10.1586/erv.09.113. Review.

PMID:
19863240
6.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on immunogenicity.

Deloria Knoll M, Park DE, Johnson TS, Chandir S, Nonyane BA, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S119-29. doi: 10.1097/INF.0000000000000079. Review.

7.

10-Valent pneumococcal non-typeable haemophilus influenzae protein D-conjugate vaccine: a review in infants and children.

Plosker GL.

Paediatr Drugs. 2014 Oct;16(5):425-44. doi: 10.1007/s40272-014-0089-x. Review.

PMID:
25192686
8.

Review of a new fully liquid, hexavalent vaccine: Hexaxim.

Nunes MC, Madhi SA.

Expert Opin Biol Ther. 2013 Apr;13(4):575-93. doi: 10.1517/14712598.2013.774368. Epub 2013 Feb 27. Review. Erratum in: Expert Opin Biol Ther. 2013 Jun;13(6):949.

PMID:
23441818
9.

The differential impact of coadministered vaccines, geographic region, vaccine product and other covariates on pneumococcal conjugate vaccine immunogenicity.

Park DE, Johnson TS, Nonyane BA, Chandir S, Conklin L, Fleming-Dutra KE, Loo JD, Goldblatt D, Whitney CG, O'Brien KL, Deloria Knoll M.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S130-9. doi: 10.1097/INF.0000000000000081. Review.

10.

Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants.

Lagos R, Munoz A, Levine MM, Watson W, Chang I, Paradiso P.

Vaccine. 2009 Apr 14;27(17):2299-305. doi: 10.1016/j.vaccine.2009.02.022. Epub 2009 Feb 13. Review.

PMID:
19428843
11.

Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) [prevenar 13®].

Duggan ST.

Drugs. 2010 Oct 22;70(15):1973-86. doi: 10.2165/11205110-000000000-00000. Review.

PMID:
20883054
12.

Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.

Gaillat J.

Med Mal Infect. 2013 Jun;43(6):215-21. doi: 10.1016/j.medmal.2013.04.005. Epub 2013 Jun 13. Review.

PMID:
23769155
13.

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.

Fleming-Dutra KE, Conklin L, Loo JD, Knoll MD, Park DE, Kirk J, Goldblatt D, Whitney CG, O'Brien KL.

Pediatr Infect Dis J. 2014 Jan;33 Suppl 2:S152-60. doi: 10.1097/INF.0000000000000083. Review.

14.

Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adults.

Sanford M.

Drugs. 2012 Jun 18;72(9):1243-55. doi: 10.2165/11209330-000000000-00000. Review.

PMID:
22686616
15.

PCVs in individuals at increased risk of pneumococcal disease: a literature review.

Fletcher MA, Balmer P, Bonnet E, Dartois N.

Expert Rev Vaccines. 2015 Jul;14(7):975-1030. doi: 10.1586/14760584.2015.1037743. Review.

PMID:
26083459
16.

Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.

Lee KY, Tsai MS, Kuo KC, Tsai JC, Sun HY, Cheng AC, Chang SY, Lee CH, Hung CC.

Hum Vaccin Immunother. 2014;10(12):3700-10. doi: 10.4161/hv.32247. Review.

17.

Immunogenicity of pneumococcal conjugate vaccines.

Eskola J.

Pediatr Infect Dis J. 2000 Apr;19(4):388-93. Review.

PMID:
10783041
18.

Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.

Caro-Aguilar I, Indrawati L, Kaufhold RM, Gaunt C, Zhang Y, Nawrocki DK, Giovarelli C, Winters MA, Smith WJ, Heinrichs J, Skinner JM.

Vaccine. 2017 Feb 7;35(6):865-872. doi: 10.1016/j.vaccine.2016.12.055. Epub 2017 Jan 10. Review.

PMID:
28087148
19.

Pneumococcal vaccination of older adults: conjugate or polysaccharide?

Fedson DS, Guppy MJ.

Hum Vaccin Immunother. 2013 Jun;9(6):1382-4. doi: 10.4161/hv.24692. Epub 2013 May 31. Review.

20.

Review on the immunogenicity and safety of PCV-13 in infants and toddlers.

Nunes MC, Madhi SA.

Expert Rev Vaccines. 2011 Jul;10(7):951-80. doi: 10.1586/erv.11.76. Review.

PMID:
21806394

Supplemental Content

Support Center